199 related articles for article (PubMed ID: 19329834)
1. [Chronic kidney disease (CKD) and bone. The clinical perspective of parathyroid interventional therapy for advanced secondary hyperparathyroidism in the era of cinacalcet HCl].
Tominaga Y
Clin Calcium; 2009 Apr; 19(4):545-50. PubMed ID: 19329834
[TBL] [Abstract][Full Text] [Related]
2. [Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
Tominaga Y
Clin Calcium; 2012 Jul; 22(7):1083-8. PubMed ID: 22750941
[TBL] [Abstract][Full Text] [Related]
3. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
4. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
Tominaga Y; Matsuoka S; Uno N; Sato T
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S21-6. PubMed ID: 19032523
[TBL] [Abstract][Full Text] [Related]
5. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].
Uemura K; Kakuta T
Clin Calcium; 2010 Jul; 20(7):1104-10. PubMed ID: 20585190
[TBL] [Abstract][Full Text] [Related]
6. Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy.
Kitaoka M
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S16-20. PubMed ID: 19032521
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
8. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Fishbane S; Shapiro WB; Corry DB; Vicks SL; Roppolo M; Rappaport K; Ling X; Goodman WG; Turner S; Charytan C
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1718-25. PubMed ID: 18945995
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for secondary hyperparathyroidism in dialysis patients.
Ogata H; Koiwa F; Ito H; Kinugasa E
Ther Apher Dial; 2006 Aug; 10(4):355-63. PubMed ID: 16911189
[TBL] [Abstract][Full Text] [Related]
13. Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.
Yajima A; Akizawa T; Tsukamoto Y; Kurihara S; Ito A;
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S38-43. PubMed ID: 19032526
[TBL] [Abstract][Full Text] [Related]
14. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
[TBL] [Abstract][Full Text] [Related]
15. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
Vulpio C; Bossola M; Di Stasio E; Tazza L; Silvestri P; Fadda G
Eur J Endocrinol; 2013 Jun; 168(6):811-9. PubMed ID: 23520248
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
[TBL] [Abstract][Full Text] [Related]
17. Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection/parathyroidectomy for secondary hyperparathyroidism.
Nakamura M; Tanaka K; Fujii T
Hemodial Int; 2017 Jul; 21(3):E45-E49. PubMed ID: 28078796
[TBL] [Abstract][Full Text] [Related]
18. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Kawata T; Imanishi Y; Kobayashi K; Onoda N; Okuno S; Takemoto Y; Komo T; Tahara H; Wada M; Nagano N; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
J Bone Miner Metab; 2006; 24(4):300-6. PubMed ID: 16816924
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism.
Vulpio C; Bossola M; De Gaetano A; Maresca G; Di Stasio E; Zagaria L; Luciani G; Giordano A; Castagneto M
Ther Apher Dial; 2010 Apr; 14(2):178-85. PubMed ID: 20438540
[TBL] [Abstract][Full Text] [Related]
20. [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
Reichel H; Braun J
Dtsch Med Wochenschr; 2011 Jan; 136(4):123-8. PubMed ID: 21181622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
